Promoting Aging and Thriving With HIV
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Meredith Greene, MD · PRINCIPAL_INVESTIGATOR · Indiana University School of Medicine, and Regenstrief Institute; IU Center for Aging Research
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility: recruitment and retentionRecruitment day one, throughout the study to final assessment six months post baseline of the last participant.
Feasibility will be measured by tracking the number of participants approached, enrolled, retained, observations by study team throughout study.
- Feasibility: patient/provider experienceAfter completing final outcomes at the 6 month assessment (or earlier if difficulty with recruitment/retention) patients and providers will be invited to participate in an optional qualitative interview.
Feasibility will be measured by qualitative Interviews with patients and providers. Interview questions will be used to derive personal anecdotes of the patient/provider experience pertaining to the feasibility of the study.
- Acceptability; General attitudes, perception of interventionAfter completing final outcomes at the 6 month assessment (or as needed if difficulty with recruitment/retention) patients and providers will be invited to participate in an optional qualitative interview.
Acceptability will be measured by qualitative Interviews with patients and providers. Interview questions will be used to derive personal anecdotes of the patient/provider general attitudes, perception of intervention.